BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG’s Interrogative Biology® Platform
FRAMINGHAM, Mass., Feb. 27, 2020 /PRNewswire/ -- BERG, a clinical stage biopharmaceutical company that uses artificial intelligence (AI) to discover...